-
1
-
-
0022379663
-
A prospective study of postmenopausal estrogen therapy and coronary heart disease
-
Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-1049.
-
(1985)
N Engl J Med
, vol.313
, pp. 1044-1049
-
-
Stampfer, M.J.1
Willett, W.C.2
Colditz, G.A.3
Rosner, B.4
Speizer, F.E.5
Hennekens, C.H.6
-
2
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
-
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
-
(1998)
JAMA
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
-
3
-
-
0034099334
-
A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: Consensus opinion of The North American Menopause Society
-
The North American Menopause Society
-
The North American Menopause Society. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause 2000;7:76-86.
-
(2000)
Menopause
, vol.7
, pp. 76-86
-
-
-
4
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
-
5
-
-
1242334352
-
Treatment of menopause-associated vasomotor symptoms: Position statement of The North American Menopause Society
-
The North American Menopause Society
-
The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11:11-33.
-
(2004)
Menopause
, vol.11
, pp. 11-33
-
-
-
6
-
-
34247588730
-
Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society
-
The North American Menopause Society
-
The North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-182.
-
(2007)
Menopause
, vol.14
, pp. 168-182
-
-
-
7
-
-
22144475839
-
Symptom experience after discontinuing use of estrogen plus progestin
-
Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183-193.
-
(2005)
JAMA
, vol.294
, pp. 183-193
-
-
Ockene, J.K.1
Barad, D.H.2
Cochrane, B.B.3
-
8
-
-
0344255781
-
Predictors of difficulty when discontinuing postmenopausal hormone therapy
-
Grady D, Ettinger B, Tosteson AN, Pressman A, Macer JL. Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol 2003;102:1233-1239.
-
(2003)
Obstet Gynecol
, vol.102
, pp. 1233-1239
-
-
Grady, D.1
Ettinger, B.2
Tosteson, A.N.3
Pressman, A.4
Macer, J.L.5
-
9
-
-
0037165669
-
A 60-year-old woman trying to discontinue hormone replacement therapy
-
Grady D. A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA 2002;287:2130-2137.
-
(2002)
JAMA
, vol.287
, pp. 2130-2137
-
-
Grady, D.1
-
10
-
-
33745252191
-
Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: A randomized prospective study
-
Haimov-Kochman R, Barak-Glantz E, Arbel R, et al. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study. Menopause 2006;13:370-376.
-
(2006)
Menopause
, vol.13
, pp. 370-376
-
-
Haimov-Kochman, R.1
Barak-Glantz, E.2
Arbel, R.3
-
11
-
-
33845461247
-
How best is to discontinue postmenopausal hormone therapy: Immediate or tapered?
-
Aslan E, Bagis T, Kilicdag EB, Tarim E, Erkanli S, Kuscu E. How best is to discontinue postmenopausal hormone therapy: immediate or tapered? Maturitas 2007;56:78-83.
-
(2007)
Maturitas
, vol.56
, pp. 78-83
-
-
Aslan, E.1
Bagis, T.2
Kilicdag, E.B.3
Tarim, E.4
Erkanli, S.5
Kuscu, E.6
-
12
-
-
67649878878
-
Discontinuing post-menopausal hormone therapy an observational study of tapering versus quitting cold turkey: Is there a difference in recurrence of menopausal symptoms
-
Haskell S, Bean-Mayberry B, Gordon K. Discontinuing post-menopausal hormone therapy an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms. Menopause. 2009;16:494-499.
-
(2009)
Menopause
, vol.16
, pp. 494-499
-
-
Haskell, S.1
Bean-Mayberry, B.2
Gordon, K.3
|